Summary of Product Characteristics
last updated on the eMC:
14/11/2008
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 14/11/2008 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 1 -Name of the Medicinal product
|
| Date of revision of text on the SPC: 01-Nov-2008 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
ADCAL Chewable Tablet Name Change:
The name of ADCAL 600mg chewable tablets has been changed to ADCAL 1500mg Chewable Tablets. This change has been made to reflect the calcium carbonate content of the product (1500mg). Previously, that name reflected the elemental calcium content in the product (600mg). NB The composition of the tablet including the content of the active ingredient, calcium carbonate, has not changed.
|
|
Updated on 14/09/2006 and displayed until 14/11/2008
|
Reasons for adding or updating:
|
-
Company name change or merger
|
| Date of revision of text on the SPC: 02/2006 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Section 7. - change of company name from Strakan Ltd to ProStrakan Ltd
|
|
Updated on 29/04/2002 and displayed until 14/09/2006
|
Reasons for adding or updating:
|
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
|
|
Updated on 22/10/2001 and displayed until 29/04/2002
|
Reasons for adding or updating:
|
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
|
|
Updated on 05/07/2001 and displayed until 22/10/2001
|
Reasons for adding or updating:
|
|
|
|
Updated on 13/02/2001 and displayed until 05/07/2001
|
Reasons for adding or updating:
|
|
|
|